A Study To Evaluate The Safety And Efficacy Of PF-04958242 In Subjects With Cognitive Impairment Associated With Schizophrenia (CIAS)

Stopped early · Phase 2 · Has a placebo group

Conditions studied: Cognitive Impairment Associated With Schizophrenia (CIAS)

In brief

The purpose of this study is to determine whether PF-04958242 is safe and effective in the treatment of cognitive dysfunction in schizophrenia subjects

Key facts

Study ID
NCT02855411
Run by
Biogen
People needed
35
Starts
2016-08-29
Expected to finish
2016-09-26
Last updated by the study team
2020-01-09

Who can join

Age: 18 and older, up to 50. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.